Entity
  • Filière Intelligence Artificielle & Cancers

    Created in 2021
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    2,812 2,812
  • Activities

  • Entity types

  • Location

    2 - 10 Rue d'Oradour-sur-Glane, 75015 Paris, France

    Paris

    France

  • Employees

    Scale: 2-10

    Estimated: 8

  • Engaged corporates

    9
    3 7
  • Added in Motherbase

    5 months, 2 weeks ago
Description
  • Value proposition

    [Automatic translation follows] Transforming data into tangible innovations.

    The "Filière Intelligence Artificielle & Cancers" Association was created on August 3, 2021. It is the result of an unprecedented public-private partnership and brings together representatives from the National Cancer Institute, the Health Data Hub, the Alliance for Research and Innovation in Health Industries, France Biotech and nine of the world's largest healthcare manufacturers in oncology: Amgen, AstraZeneca, Bristol-Myers Squibb, Janssen, MSD, Novartis, Pfizer, Pierre Fabre and Roche diagnostic.

    Its ambition is to address, through all the data available in France, questions that bring value to patients and are transformed into tangible innovations in the field of cancerology.

    Artificial Intelligence, Cancerology, and Health Data

  • Original language

    Transformer des données en innovations tangibles.

    L’Association "Filière Intelligence Artificielle & Cancers" a été créée le 3 août 2021. Elle est le fruit d’un partenariat public privé inédit et rassemble des représentants de l'Institut national du cancer, du Health Data Hub, de l'Alliance pour la Recherche et l'Innovation des Industries de Santé, de France Biotech et de neuf des plus gros industriels de santé mondiaux en oncologie : Amgen, AstraZeneca, Bristol-Myers Squibb, Janssen, MSD, Novartis, Pfizer, Pierre Fabre et Roche diagnostic.

    Son ambition est d'adresser, à travers toutes les données disponibles en France, des questions qui apportent de la valeur aux patients et se transforment en innovations tangibles dans le domaine de la cancérologie.

    Intelligence Artificielle, Cancérologie, and Données de santé

Corporate interactions BETA
Corporate TypeTweets Articles
Institut Curie
Institut Curie
Health, Hospitals and Health Care
Institut Curie
Health, Hospitals and Health Care
Other

23 Sep 2024


Johnson & Johnson
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care
Other

25 Jun 2024


Pierre Fabre Laboratories
Pierre Fabre Laboratories
Pharmaceutical, Pharmaceutical Manufacturing
Pierre Fabre Laboratories
Pharmaceutical, Pharmaceutical Manufacturing
Other

19 Jun 2024


La Tribune
La Tribune
Media, Newspapers
La Tribune
Media, Newspapers
Other

25 Apr 2024


France Biotech
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
Other

30 Aug 2024


BioValley France
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

11 Jan 2024


DOCAPOSTE
DOCAPOSTE
IT services, IT Services and IT Consulting
DOCAPOSTE
IT services, IT Services and IT Consulting
Other

2 May 2024


AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
Other

2 Jul 2024


MSD
MSD
Pharmaceutical, Pharmaceutical Manufacturing
MSD
Pharmaceutical, Pharmaceutical Manufacturing
Other

2 May 2024


Similar entities
Loading...
Loading...
Social network dynamics